344 related articles for article (PubMed ID: 15457501)
1. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome.
Bowirrat A; Oscar-Berman M
Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):29-37. PubMed ID: 15457501
[TBL] [Abstract][Full Text] [Related]
2. Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.
Blum K; Braverman ER; Holder JM; Lubar JF; Monastra VJ; Miller D; Lubar JO; Chen TJ; Comings DE
J Psychoactive Drugs; 2000 Nov; 32 Suppl():i-iv, 1-112. PubMed ID: 11280926
[TBL] [Abstract][Full Text] [Related]
3. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
4. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
5. Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.
Blum K; Chen AL; Oscar-Berman M; Chen TJ; Lubar J; White N; Lubar J; Bowirrat A; Braverman E; Schoolfield J; Waite RL; Downs BW; Madigan M; Comings DE; Davis C; Kerner MM; Knopf J; Palomo T; Giordano JJ; Morse SA; Fornari F; Barh D; Femino J; Bailey JA
Int J Environ Res Public Health; 2011 Dec; 8(12):4425-59. PubMed ID: 22408582
[TBL] [Abstract][Full Text] [Related]
6. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review.
Noble EP
Eur Psychiatry; 2000 Mar; 15(2):79-89. PubMed ID: 10881203
[TBL] [Abstract][Full Text] [Related]
7. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Blum K; Chen TJ; Downs BW; Bowirrat A; Waite RL; Braverman ER; Madigan M; Oscar-Berman M; DiNubile N; Stice E; Giordano J; Morse S; Gold M
Postgrad Med; 2009 Nov; 121(6):176-96. PubMed ID: 19940429
[TBL] [Abstract][Full Text] [Related]
8. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
[TBL] [Abstract][Full Text] [Related]
9. Attention-deficit-hyperactivity disorder and reward deficiency syndrome.
Blum K; Chen AL; Braverman ER; Comings DE; Chen TJ; Arcuri V; Blum SH; Downs BW; Waite RL; Notaro A; Lubar J; Williams L; Prihoda TJ; Palomo T; Oscar-Berman M
Neuropsychiatr Dis Treat; 2008 Oct; 4(5):893-918. PubMed ID: 19183781
[TBL] [Abstract][Full Text] [Related]
10. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
Wang TJ; Huang SY; Lin WW; Lo HY; Wu PL; Wang YS; Wu YS; Ko HC; Shih JC; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):108-14. PubMed ID: 17007976
[TBL] [Abstract][Full Text] [Related]
11. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders.
Noble EP
Alcohol Alcohol Suppl; 1994; 2():35-43. PubMed ID: 8974314
[TBL] [Abstract][Full Text] [Related]
13. The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients.
Ponce G; Jimenez-Arriero MA; Rubio G; Hoenicka J; Ampuero I; Ramos JA; Palomo T
Eur Psychiatry; 2003 Nov; 18(7):356-60. PubMed ID: 14643564
[TBL] [Abstract][Full Text] [Related]
14. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
[TBL] [Abstract][Full Text] [Related]
16. D2 dopamine receptor gene and cigarette smoking: a reward gene?
Noble EP; St Jeor ST; Ritchie T; Syndulko K; St Jeor SC; Fitch RJ; Brunner RL; Sparkes RS
Med Hypotheses; 1994 Apr; 42(4):257-60. PubMed ID: 8072432
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.
Blum K; Sheridan PJ; Wood RC; Braverman ER; Chen TJ; Comings DE
Pharmacogenetics; 1995 Jun; 5(3):121-41. PubMed ID: 7550364
[TBL] [Abstract][Full Text] [Related]
18. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K; Chen AL; Chen TJ; Braverman ER; Reinking J; Blum SH; Cassel K; Downs BW; Waite RL; Williams L; Prihoda TJ; Kerner MM; Palomo T; Comings DE; Tung H; Rhoades P; Oscar-Berman M
Theor Biol Med Model; 2008 Nov; 5():24. PubMed ID: 19014506
[TBL] [Abstract][Full Text] [Related]
19. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
Blum K; Baron D; McLaughlin T; Gold MS
J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
[TBL] [Abstract][Full Text] [Related]
20. [Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients].
Heinz A
Nervenarzt; 1999 May; 70(5):399-407. PubMed ID: 10407835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
